Tibet Rhodiola Pharmaceutical Holding financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥182.66M ¥696.48M ¥863.02M ¥823.24M ¥991.07M ¥1.11B ¥1.11B ¥1.08B ¥1.22B ¥1.40B ¥1.67B ¥1.38B ¥796.81M ¥915.63M ¥1.03B ¥1.26B ¥1.37B ¥2.14B ¥2.55B ¥3.13B ¥0.00M
GM % Gross Margin %
45.83% 16.94% 25.96% 11.99% 14.72% 16.76% 17.14% 17.73% 19.70% 19.83% 20.24% 32.30% 76.31% 73.75% 79.90% 83.45% 85.75% 89.44% 91.99% 94.94% 0.00%
OM Operating Margin
2.38% -4.76% -0.05% -15.52% 0.35% 0.77% 1.51% 0.97% 1.78% 1.61% 1.82% 5.36% 24.69% 24.78% 24.52% 27.07% 29.66% 26.78% 26.94% 33.14% 0.00%
EPS Earnings Per Share
¥0.04 ¥-0.57 ¥0.11 ¥0.09 ¥0.11 ¥0.32 ¥0.82 ¥0.61 ¥1.22 ¥3.16 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.04 ¥0.14 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.74 ¥0.00
PR % Payout Ratio %
0 0 0.00% -0.00% 0 0 0 0 0 0 0 43.75% 0.00% 0 0 0 0 0 0 23.42% 0
Sha. Shares
171.71m 171.71m 171.71m 171.71m 175.86m 175.86m 175.86m 203.82m 203.82m 203.82m 203.82m 203.82m 203.82m 251.47m 251.47m 247.94m 247.94m 247.94m 247.94m 0m 247.94m
OCF Operating Cash Flow
¥26.90M ¥0.00M ¥31.56M ¥-18.30M ¥21.46M ¥17.88M ¥1.90M ¥12.09M ¥56.20M ¥279.22M ¥-141.40M ¥133.93M ¥250.20M ¥91.46M ¥289.22M ¥489.59M ¥428.17M ¥366.53M ¥837.38M ¥1.06B ¥0.00M
FCF Free Cash Flow
¥9.45M ¥0.00M ¥15.33M ¥-35.68M ¥16.66M ¥14.18M ¥-0.68M ¥9.78M ¥51.78M ¥245.10M ¥-169.32M ¥123.29M ¥240.56M ¥-516.52M ¥265.85M ¥440.59M ¥206.88M ¥-59.05M ¥735.42M ¥1.04B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥0.00 ¥0.06 ¥-0.17 ¥0.08 ¥0.07 ¥-0.00 ¥0.05 ¥0.25 ¥1.21 ¥-0.83 ¥0.60 ¥1.18 ¥-2.19 ¥1.06 ¥1.76 ¥0.84 ¥-0.24 ¥2.96 ¥4.20 ¥0.00